Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 97, Issue 8, Pages 962-970
Publisher
Springer Nature
Online
2017-04-17
DOI
10.1038/labinvest.2017.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1
- (2016) Taro Sugiyama et al. CANCER SCIENCE
- Targeting transcription factor STAT3 for cancer prevention and therapy
- (2016) Edna Zhi Pei Chai et al. PHARMACOLOGY & THERAPEUTICS
- MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer
- (2015) Kohei Taniguchi et al. CANCER LETTERS
- Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
- (2015) S Calabretta et al. ONCOGENE
- PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells
- (2015) Jihua Guo et al. Scientific Reports
- Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer
- (2015) Qiong Li et al. Scientific Reports
- Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties
- (2014) X He et al. Oncogenesis
- Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma
- (2013) S. R. P. McDonnell et al. BLOOD
- Reciprocal Regulation of Protein Kinase and Pyruvate Kinase Activities of Pyruvate Kinase M2 by Growth Signals
- (2013) Xueliang Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
- (2012) Xueliang Gao et al. MOLECULAR CELL
- Targeting ALK in neuroblastoma—preclinical and clinical advancements
- (2012) Erica L. Carpenter et al. Nature Reviews Clinical Oncology
- PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis
- (2011) Daisy I. Izaguirre et al. MOLECULAR CARCINOGENESIS
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- Crizotinib in Anaplastic Large-Cell Lymphoma
- (2011) Carlo Gambacorti-Passerini et al. NEW ENGLAND JOURNAL OF MEDICINE
- NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis
- (2011) S R P McDonnell et al. ONCOGENE
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity
- (2010) Gregory R. Ott et al. ACS Medicinal Chemistry Letters
- Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
- (2009) T. Hitosugi et al. Science Signaling
- Pyruvate kinase M2 is a phosphotyrosine-binding protein
- (2008) Heather R. Christofk et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More